Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Trials & Approvals

Updates on new clinical tirals being performed in China, trial updates and drug approvals...

Bioheng Publishes Positive Results for Universal CAR-T in Hematological Malignancies

Keymed’s Claudin 18.2 ADC Granted China Breakthrough Status for Gastric Cancer

RemeGen Reports Positive Results from Confirmatory Trial of Lupus Therapy

Frontera Approved to Start China Trial of Gene Therapy for Inherited Retinal Degeneration

Belite Bio Starts China Trial of Therapy for Stargardt, an Inherited Renal Disease

ChinaBio Event
Beijing and Digital
November 8-11, 2022
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
July 27-31, 2022